JP2022512650A5 - - Google Patents

Info

Publication number
JP2022512650A5
JP2022512650A5 JP2021519644A JP2021519644A JP2022512650A5 JP 2022512650 A5 JP2022512650 A5 JP 2022512650A5 JP 2021519644 A JP2021519644 A JP 2021519644A JP 2021519644 A JP2021519644 A JP 2021519644A JP 2022512650 A5 JP2022512650 A5 JP 2022512650A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
variant
reference antibody
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021519644A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512650A (ja
JP7853096B2 (ja
Filing date
Publication date
Priority claimed from GBGB1817188.4A external-priority patent/GB201817188D0/en
Priority claimed from GBGB1904754.7A external-priority patent/GB201904754D0/en
Priority claimed from GBGB1905032.7A external-priority patent/GB201905032D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/053010 external-priority patent/WO2020084298A1/en
Publication of JP2022512650A publication Critical patent/JP2022512650A/ja
Priority to JP2025167548A priority Critical patent/JP2026016427A/ja
Publication of JP2022512650A5 publication Critical patent/JP2022512650A5/ja
Application granted granted Critical
Publication of JP7853096B2 publication Critical patent/JP7853096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021519644A 2018-10-22 2019-10-22 抗体ライブラリー及び方法 Active JP7853096B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025167548A JP2026016427A (ja) 2018-10-22 2025-10-03 抗体ライブラリー及び方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1817188.4A GB201817188D0 (en) 2018-10-22 2018-10-22 Antibody library
GB1817188.4 2018-10-22
GB1904754.7 2019-04-04
GBGB1904754.7A GB201904754D0 (en) 2019-04-04 2019-04-04 Antibody library and method
GBGB1905032.7A GB201905032D0 (en) 2019-04-09 2019-04-09 Antibody library and method
GB1905032.7 2019-04-09
PCT/GB2019/053010 WO2020084298A1 (en) 2018-10-22 2019-10-22 Antibody library and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025167548A Division JP2026016427A (ja) 2018-10-22 2025-10-03 抗体ライブラリー及び方法

Publications (3)

Publication Number Publication Date
JP2022512650A JP2022512650A (ja) 2022-02-07
JP2022512650A5 true JP2022512650A5 (https=) 2025-10-30
JP7853096B2 JP7853096B2 (ja) 2026-04-28

Family

ID=68393020

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021519644A Active JP7853096B2 (ja) 2018-10-22 2019-10-22 抗体ライブラリー及び方法
JP2025167548A Pending JP2026016427A (ja) 2018-10-22 2025-10-03 抗体ライブラリー及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025167548A Pending JP2026016427A (ja) 2018-10-22 2025-10-03 抗体ライブラリー及び方法

Country Status (10)

Country Link
US (2) US12378696B2 (https=)
EP (1) EP3870607A1 (https=)
JP (2) JP7853096B2 (https=)
KR (1) KR20210084509A (https=)
CN (1) CN113195537A (https=)
AU (1) AU2019365135A1 (https=)
BR (1) BR112021007529A2 (https=)
CA (1) CA3115150A1 (https=)
MX (1) MX2021004149A (https=)
WO (1) WO2020084298A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7473339B2 (ja) * 2017-03-07 2024-04-23 エフ. ホフマン-ラ ロシュ アーゲー 代替の抗原特異的抗体変異体を発見するための方法
CN112289369B (zh) * 2020-12-15 2021-04-02 武汉华美生物工程有限公司 一种基于深度学习的抗体库构建方法及装置
CN114775065B (zh) * 2022-04-22 2026-01-06 武汉华美生物工程有限公司 一种半合成纳米抗体库构建方法和纳米抗体库
CN115171774A (zh) * 2022-05-17 2022-10-11 慧壹科技(上海)有限公司 一种抗体/大分子药物的亲和力改造系统和方法
CN117736329B (zh) * 2023-12-25 2024-11-12 华润生物医药有限公司 抗pd-1抗体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2011801A1 (en) * 1999-05-27 2009-01-07 Government of the United States as represented by the Secretary, Department of Health and Human Services Immunoconjugates having high binding affinity
WO2016188911A1 (en) * 2015-05-22 2016-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Human monoclonal antibodies fragments inhibiting both the cath-d catalytic activity and its binding to the lrp1 receptor
CN109576292B (zh) * 2018-12-21 2022-11-29 深圳市爱思迪生物科技有限公司 一种抗体文库的构建方法及其应用

Similar Documents

Publication Publication Date Title
JP2022512650A5 (https=)
JP2022043042A5 (https=)
JP2025072570A (ja) 共転写キャッピング用rnaポリメラーゼバリアント
JP2024010112A5 (https=)
Podobnik et al. A TOPRIM domain in the crystal structure of the catalytic core of Escherichia coli primase confirms a structural link to DNA topoisomerases
JP2007530435A5 (https=)
JP2019523753A5 (https=)
JP2017500035A5 (https=)
JP2010273685A5 (https=)
JP2012512641A5 (https=)
JP2008525033A5 (https=)
JP2019519216A5 (https=)
JP7370580B2 (ja) 結合および生物活性を改善した腫瘍壊死因子受容体(tnfr)結合タンパク質複合体
JP2020536888A5 (https=)
JP2017070289A5 (https=)
JP2019522961A5 (https=)
JP2019513784A5 (https=)
JP2011087580A5 (https=)
JP2019527543A5 (https=)
US12173046B2 (en) TNFR2 agonists with improved stability
Morrison et al. Use of the polymerase chain reaction to clone and sequence a cDNA encoding the bovine alpha 3 chain of type IV collagen.
JP2009545319A5 (https=)
JP2020537520A5 (https=)
HRP20141214T1 (hr) Molekule antitijela sa specifiäśnosti za humani 6-il
JP2023171909A5 (https=)